Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Lymphoma 539 Precursor Cell Lymphoblastic Leukemia-Lymphoma 499 Lymphoma, Non-Hodgkin 435 Lymphoma, Follicular 403 Leukemia, Lymphocytic, Chronic, B-Cell 388 Lymphoma, Large B-Cell, Diffuse 385 Lymphoma, B-Cell 246 Lymphoma, Mantle-Cell 222 Hodgkin Disease 207 Recurrence 204 Leukemia, Myeloid, Acute 197 Leukemia 191 Multiple Myeloma 184 Burkitt Lymphoma 181 Lymphoma, B-Cell, Marginal Zone 170 Neoplasms 151 Myelodysplastic Syndromes 132 Hematologic Neoplasms 115 Waldenstrom Macroglobulinemia 103 Lymphoma, T-Cell, Peripheral 85 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81 Lymphoma, T-Cell 81 Lymphoma, T-Cell, Cutaneous 66 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 62 Mycosis Fungoides 57 Leukemia, Biphenotypic, Acute 54 Breast Neoplasms 54 Myeloproliferative Disorders 50 Leukemia, B-Cell 50 Lymphoproliferative Disorders 47

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anosmia × Lymphoid × 1 year × Clear all

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡